ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 157 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $306,963 | -20.4% | 27,481 | +188.3% | 0.00% | -50.0% |
Q1 2023 | $385,515 | -40.0% | 9,533 | -31.0% | 0.00% | -33.3% |
Q4 2022 | $642,813 | +138.1% | 13,818 | +165.1% | 0.00% | +200.0% |
Q3 2022 | $270,000 | +24.4% | 5,213 | +5.9% | 0.00% | 0.0% |
Q2 2021 | $217,000 | -10.0% | 4,924 | -6.6% | 0.00% | -66.7% |
Q3 2020 | $241,000 | -26.5% | 5,271 | -19.4% | 0.00% | -40.0% |
Q2 2020 | $328,000 | -70.5% | 6,537 | -69.8% | 0.01% | -82.1% |
Q1 2020 | $1,111,000 | +50.7% | 21,611 | +81.0% | 0.03% | +600.0% |
Q4 2019 | $737,000 | -64.4% | 11,937 | -65.4% | 0.00% | -78.9% |
Q3 2019 | $2,073,000 | +241.5% | 34,498 | +379.5% | 0.02% | +216.7% |
Q2 2019 | $607,000 | -38.9% | 7,195 | -30.8% | 0.01% | -45.5% |
Q1 2019 | $994,000 | -37.0% | 10,404 | -53.3% | 0.01% | -38.9% |
Q4 2018 | $1,579,000 | +79.2% | 22,291 | +116.3% | 0.02% | +63.6% |
Q3 2018 | $881,000 | -57.7% | 10,304 | -42.7% | 0.01% | -60.7% |
Q2 2018 | $2,085,000 | +6.6% | 17,990 | -25.6% | 0.03% | -9.7% |
Q1 2018 | $1,956,000 | +25.9% | 24,177 | -8.6% | 0.03% | +14.8% |
Q4 2017 | $1,553,000 | +473.1% | 26,466 | +226.8% | 0.03% | +145.5% |
Q4 2016 | $271,000 | +14.8% | 8,098 | -8.9% | 0.01% | -31.2% |
Q3 2016 | $236,000 | +0.4% | 8,885 | +11.1% | 0.02% | -11.1% |
Q1 2016 | $235,000 | -43.2% | 8,000 | -36.2% | 0.02% | -60.0% |
Q4 2015 | $414,000 | – | 12,532 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |